RECEPTOR HOLDINGS, INC.

Profile

Company Names

RECEPTOR HOLDINGS, INC.

Addresses

1200 FIFTH AVENUE, SUITE 1400, SEATTLE, WA 98101

C/O LANE POWELL PC, 1420 5TH AVE., SUITE 4200, SEATTLE, WA 98101

Phone Numbers

206-483-2730

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, OTHER

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$36,176,291.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-12-06 
$7,299,313.00 
$10,000,000.00 
$2,700,687.00 
Equity 
1
2018-10-15 
$28,876,978.00 
$30,000,000.00 
$1,123,022.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TRACI 
 
CARMAN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
RECEPTOR LIFE SCIENCES, INC.   |  RECEPTOR HOLDINGS, INC.
ORRIN 
 
DEVINSKY, MD, PHD 
DIRECTOR
RECEPTOR HOLDINGS, INC.
STEPHEN 
 
HOFFMAN, MD, PHD 
DIRECTOR
RECEPTOR HOLDINGS, INC.
WARREN 
 
LAMMERT 
DIRECTOR
BISCAYNE PHARMACEUTICALS INC.   |  ENGAGE THERAPEUTICS, INC.   |  CEREBRAL THERAPEUTICS, INC.   |  RECEPTOR HOLDINGS, INC.
ANDREA 
 
LEONE-BAY 
EXECUTIVE OFFICER, PROMOTER
RECEPTOR HOLDINGS, INC.   |  SPOKE SCIENCES, INC.
GREGORY 
 
MAYES 
DIRECTOR
UNIGENE LABORATORIES INC   |  ENGAGE THERAPEUTICS, INC.   |  ANTIOS THERAPEUTICS INC.   |  RECEPTOR HOLDINGS, INC.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  REUNION NEUROSCIENCE, INC.
ARTHUR 
 
RUBINFELD 
DIRECTOR
PROPEL BIOFUELS, INC.   |  PHO-NOMENAL, INC.   |  RECEPTOR LIFE SCIENCES, INC.   |  RECEPTOR HOLDINGS, INC.   |  CLAIRE-S HOLDINGS LLC
MARK 
 
THEEUWES 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ENGAGE THERAPEUTICS, INC.   |  RECEPTOR HOLDINGS, INC.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  REUNION NEUROSCIENCE, INC.
JIM 
 
WEISSMAN 
DIRECTOR
RECEPTOR HOLDINGS, INC.
GREG 
 
WESNER 
DIRECTOR
RECEPTOR HOLDINGS, INC.
GREGORY 
 
WESNER 
DIRECTOR
RECEPTOR LIFE SCIENCES, INC.   |  RECEPTOR HOLDINGS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-12-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-06 
2018-10-29
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-10-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#